LY-2510924

LY-2510924 is a synthetic peptide compound that functions as a potent and selective antagonist of the chemokine receptor CXCR4. Structurally designed to mimic key ligand-receptor interactions, it blocks the binding of stromal cell-derived factor-1 (SDF-1 or CXCL12) to CXCR4, thereby modulating downstream signaling pathways. As a research tool, LY-2510924 has gained prominence in the study of chemokine-driven cellular processes, particularly those involving cell migration, immune cell trafficking, and tumor microenvironment dynamics. Its well-characterized mode of action and high receptor specificity make it a valuable asset for investigating CXCR4-mediated biological phenomena in both fundamental and applied biochemical research.

Receptor signaling studies: LY-2510924 is widely employed in the dissection of CXCR4-mediated signaling cascades. By competitively inhibiting the interaction between CXCR4 and its endogenous ligand, the peptide enables researchers to precisely delineate the downstream effects of receptor activation or blockade. This is particularly important for mapping G protein-coupled receptor (GPCR) pathways, identifying secondary messengers, and characterizing cellular responses such as calcium flux, chemotaxis, and gene expression changes. Its use facilitates a deeper understanding of chemokine receptor biology and the intricate signaling networks governing cell behavior.

Tumor microenvironment research: The CXCR4/CXCL12 axis plays a pivotal role in tumor progression, metastasis, and the establishment of supportive stromal niches. LY-2510924 serves as a critical tool for probing the functional consequences of CXCR4 inhibition within cancer models. By disrupting chemokine gradients, it allows investigators to study alterations in tumor cell migration, invasion, and interaction with the extracellular matrix. These insights are essential for elucidating mechanisms of metastasis and for evaluating the potential of CXCR4 antagonists as research leads in oncology.

Immune cell trafficking analysis: The migration and homing of immune cells, including lymphocytes and hematopoietic progenitors, are tightly regulated by chemokine receptors such as CXCR4. LY-2510924 is utilized in experimental systems to block CXCR4-dependent cell movement, enabling the study of immune cell distribution, tissue infiltration, and mobilization from bone marrow or peripheral compartments. Such applications are fundamental for advancing knowledge of immune surveillance, inflammatory responses, and hematopoietic dynamics.

Peptide ligand-receptor interaction assays: As a synthetic peptide antagonist, LY-2510924 is frequently incorporated into binding assays designed to quantify ligand-receptor affinities and to screen for novel modulators of CXCR4 activity. Its high specificity and well-characterized binding profile make it a reliable reference compound in competitive displacement experiments, fluorescence polarization studies, and surface plasmon resonance analyses. These assays contribute to a more nuanced understanding of chemokine receptor pharmacology and support the development of new chemical probes.

Peptide synthesis and structure-activity relationship (SAR) studies: The rational design and optimization of peptide-based CXCR4 antagonists benefit from the inclusion of LY-2510924 as a benchmark compound. Researchers leverage its structural features and biological activity to guide the synthesis of analogs, evaluate modifications, and establish SAR correlations. Such work is instrumental in refining the pharmacological properties of new peptides and in expanding the toolkit available for chemokine receptor research.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)